Participants in the T1D Exchange Clinic Network retained the ability to secrete an incompletely processed form of insulin, even when their diabetes was longstanding. The results, generated in part from T1D Exchange Biobank data and samples, suggest a story of how type 1 diabetes might progress.

We think of glucagon as a medication to treat lows, part of our emergency kits. But what if we could change the way our body uses glucagon to actually manage our highs and lows? New research suggests that might be possible.

Such findings underscore the need for mental health support for people with type 1 diabetes.

Researchers have also found evidence that mini-dose glucagon may curb post-exercise hyperglycemia in people with type 1 diabetes.

Plus eight other key takeaways from a landmark study of thousands of T1D Exchange Registry participants.

A news report tells of a dramatic rescue, but is short on facts about diabetes.

Researchers have recently made some progress in the delivery mechanisms of oral insulin, but that’s just part of the equation.

In her speech, the senator strikes a chord that will sound familiar to #insulin4all activists.

Providers, patients, and parents from the T1D Exchange Quality Improvement Collaborative share guidelines for blood sugar management during illness.

Pediatric endocrinologist Sarah D. Corathers works with a special group of colleagues to tailor diabetes management to individual needs.